Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-04-014916
Filing Date
2004-03-10
Accepted
2004-03-10 15:35:08
Documents
2
Period of Report
2004-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 DATED 03/10/2004 rrd36258.html 3  
1 FORM 3 DATED 03/10/2004 rrd36258.xml 3 6357
3 POWER OF ATTORNEY rrd27873_31562.htm EX-24.1 3016
  Complete submission text file 0001181431-04-014916.txt   11097
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1124 COLUMBIA STE 130 SEATTLE WA 98103
Business Address
CORDOVA L KATHI (Reporting) CIK: 0001282807 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 04660124